{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:46:46Z","timestamp":1790754406879,"version":"4.1.0"},"reference-count":35,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,2,21]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.2967\/jnumed.126.272073","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T18:35:13Z","timestamp":1776364513000},"page":"1070-1078","source":"Crossref","is-referenced-by-count":2,"title":["Circulating Tumor DNA Genomic Profiling in\n                    <sup>223<\/sup>\n                    Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study"],"prefix":"10.2967","volume":"67","author":[{"given":"Masaki","family":"Shiota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Enokida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Kamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Masumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Higashijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Mitsunari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroji","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousei","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2026070106450728000_67.7.1070.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70028"},{"key":"2026070106450728000_67.7.1070.2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/jjco\/hyae079","article-title":"Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan: a nationwide multi-institutional study","volume":"54","author":"Kawai","year":"2024","journal-title":"Jpn J Clin Oncol."},{"key":"2026070106450728000_67.7.1070.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213755"},{"key":"2026070106450728000_67.7.1070.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70183-4"},{"key":"2026070106450728000_67.7.1070.5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw065"},{"key":"2026070106450728000_67.7.1070.6","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2013.110"},{"key":"2026070106450728000_67.7.1070.7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu239"},{"key":"2026070106450728000_67.7.1070.8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw037"},{"key":"2026070106450728000_67.7.1070.9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-2328"},{"key":"2026070106450728000_67.7.1070.10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s44276-024-00049-7","article-title":"Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project","volume":"2","author":"Shiota","year":"2024","journal-title":"BJC Rep."},{"key":"2026070106450728000_67.7.1070.11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.euo.2024.08.006","article-title":"Liquid biopsy in progressing prostate cancer patients starting docetaxel with or without enzalutamide: a biomarker study of the PRESIDE phase 3b trial","volume":"8","author":"Ruiz-Vico","year":"2025","journal-title":"Eur Urol Oncol."},{"key":"2026070106450728000_67.7.1070.12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/cas.70293","article-title":"Effectiveness and safety of radium-223 for bone-metastatic castration-resistant prostate cancer: the KYUCOG-1901 study","volume":"117","author":"Shiota","year":"2026","journal-title":"Cancer Sci."},{"key":"2026070106450728000_67.7.1070.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.01.037"},{"key":"2026070106450728000_67.7.1070.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2026070106450728000_67.7.1070.15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702"},{"key":"2026070106450728000_67.7.1070.16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1121"},{"key":"2026070106450728000_67.7.1070.17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1222"},{"key":"2026070106450728000_67.7.1070.18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603"},{"key":"2026070106450728000_67.7.1070.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004873"},{"key":"2026070106450728000_67.7.1070.20","doi-asserted-by":"crossref","first-page":"djx118","DOI":"10.1093\/jnci\/djx118","article-title":"Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer","volume":"109","author":"Wyatt","year":"2017","journal-title":"J Natl Cancer Inst."},{"key":"2026070106450728000_67.7.1070.21","doi-asserted-by":"crossref","first-page":"e2400472","DOI":"10.1200\/PO-24-00472","article-title":"Clinical utility of serial circulating tumor DNA analysis as a minimally invasive biomarker in advanced urothelial cancer","volume":"9","author":"Sakatani","year":"2025","journal-title":"JCO Precis Oncol."},{"key":"2026070106450728000_67.7.1070.22","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/s41467-024-45475-w","article-title":"Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer","volume":"15","author":"Fonseca","year":"2024","journal-title":"Nat Commun."},{"key":"2026070106450728000_67.7.1070.23","doi-asserted-by":"crossref","first-page":"e2300156","DOI":"10.1200\/PO.23.00156","article-title":"Liquid biopsies for early response evaluation of radium-223 in metastatic prostate cancer","volume":"7","author":"de Jong","year":"2023","journal-title":"JCO Precis Oncol."},{"key":"2026070106450728000_67.7.1070.24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00029","article-title":"Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making","volume":"1","author":"Abida","year":"2017","journal-title":"JCO Precis Oncol."},{"key":"2026070106450728000_67.7.1070.25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eururo.2018.11.045","article-title":"Compound genomic alterations of TP53, PTEN, and RB1 tumor suppressors in localized and metastatic prostate cancer","volume":"76","author":"Hamid","year":"2019","journal-title":"Eur Urol."},{"key":"2026070106450728000_67.7.1070.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-021-00430-4"},{"key":"2026070106450728000_67.7.1070.27","doi-asserted-by":"publisher","DOI":"10.1172\/jci132031"},{"key":"2026070106450728000_67.7.1070.28","doi-asserted-by":"crossref","first-page":"e71085","DOI":"10.1002\/cam4.71085","article-title":"Nationwide genomic data analysis of Japanese prostate cancer patients from C-CAT database","volume":"14","author":"Tsukahara","year":"2025","journal-title":"Cancer Med."},{"key":"2026070106450728000_67.7.1070.29","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/pros.24375","article-title":"The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases","volume":"82","author":"Liu","year":"2022","journal-title":"Prostate."},{"key":"2026070106450728000_67.7.1070.30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.eururo.2018.09.040","article-title":"Efficacy of radium-223 in bone-metastatic castration-resistant prostate cancer with and without homologous repair gene defects","volume":"76","author":"Isaacsson Velho","year":"2019","journal-title":"Eur Urol."},{"key":"2026070106450728000_67.7.1070.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.05.001"},{"key":"2026070106450728000_67.7.1070.32","doi-asserted-by":"crossref","first-page":"665.e1","DOI":"10.1016\/j.urolonc.2025.06.004","article-title":"Survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination deficiencies (HRD) treated with radium 223: Princess Margaret Cancer Centre (PMCC) experience","volume":"43","author":"Al-Ezzi","year":"2025","journal-title":"Urol Oncol."},{"key":"2026070106450728000_67.7.1070.33","doi-asserted-by":"crossref","first-page":"101987","DOI":"10.1016\/j.toxrep.2025.101987","article-title":"PTEN-mediated resistance in cancer: from foundation to future therapies","volume":"14","author":"Tufail","year":"2025","journal-title":"Toxicol Rep."},{"key":"2026070106450728000_67.7.1070.34","doi-asserted-by":"crossref","first-page":"100282","DOI":"10.1016\/j.jlb.2024.100282","article-title":"Genomic characterization of metastatic patterns in prostate cancer using circulating tumor DNA data from the SCRUM-Japan MONSTAR SCREEN project","volume":"7","author":"Shiota","year":"2025","journal-title":"J Liq Biopsy."},{"key":"2026070106450728000_67.7.1070.35","doi-asserted-by":"crossref","first-page":"e2300230","DOI":"10.1200\/PO.23.00230","article-title":"Circulating and imaging biomarkers of radium-223 response in metastatic castration-resistant prostate cancer","volume":"8","author":"Saylor","year":"2024","journal-title":"JCO Precis Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:05:37Z","timestamp":1782914737000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.2967\/jnumed.126.272073"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272073","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}